{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:14:12Z","timestamp":1790723652504,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bacterial vaginosis (BV) is a common condition in reproductive-age women and is known to be positively associated with risk of acquisition of sexually transmitted infections (STI) such as chlamydia and gonorrhea. <jats:italic>Mycoplasma genitalium<\/jats:italic> is an emerging STI that has been linked to increased risk of pelvic inflammatory disease, adverse pregnancy outcomes and infertility. In the present study we sought to examine whether women diagnosed with symptomatic BV were at increased risk of having concurrent infection with <jats:italic>Mycoplasma genitalium<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used a novel PCR-based assay (<jats:italic>ResistancePlus<\/jats:italic> MG; SpeeDx Pty. Ltd., Sydney, Australia) to determine the prevalence of <jats:italic>Mycoplasma genitalium<\/jats:italic> infection and 23S rRNA macrolide-resistance mediating mutations (MRMM) in a cohort of 1532 women presenting with symptoms of vaginitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>M. genitalium<\/jats:italic> was detected in 4.0% (62\/1532) of samples with 37.1% (23\/62) harboring MRMMs. The prevalence of <jats:italic>M. genitalium<\/jats:italic> infection in subjects with BV was significantly higher than in subjects with non-BV vaginitis (7.0% v 3.6%; OR\u2009=\u20091.97 (95% CI: 1.14\u20133.39).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Prevalence of <jats:italic>M. genitalium<\/jats:italic> infection is associated with BV in women with symptomatic vaginitis. Improved management of BV is needed as a component of STI prevention strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-020-00926-6","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T15:02:46Z","timestamp":1585234966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prevalence of Mycoplasma genitalium infection in women with bacterial vaginosis"],"prefix":"10.1186","volume":"20","author":[{"given":"Melinda B.","family":"Nye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla B.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Pherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"key":"926_CR1","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S0140-6736(81)92461-2","volume":"317","author":"JG Tully","year":"1981","unstructured":"Tully JG, Taylor-Robinson D, Cole RM, Rose DL. A newly discovered mycoplasma in the human urogenital tract. Lancet. 1981;317:1288\u201391.","journal-title":"Lancet"},{"key":"926_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/OLQ.0b013e3181b01948","volume":"36","author":"C Gaydos","year":"2009","unstructured":"Gaydos C, Maldeis NE, Hardick A, et al. Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis. 2009;36:598\u2013606.","journal-title":"Sex Transm Dis"},{"key":"926_CR3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/sti.2004.012062","volume":"81","author":"C Anagrius","year":"2005","unstructured":"Anagrius C, Lore B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect. 2005;81:458\u201362.","journal-title":"Sex Transm Infect"},{"key":"926_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/cid\/civ312","volume":"61","author":"R Lis","year":"2015","unstructured":"Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61:418\u201326.","journal-title":"Clin Infect Dis"},{"key":"926_CR5","unstructured":"Australian STI management guidelines for use in primary care: Mycoplasma genitalium. Australasian Sexual Health Alliance (www.sti.guidelines.org.au). 2018."},{"key":"926_CR6","unstructured":"Soni S, Horner P, Rayment M, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (www.bassh.org\/guidelines). 2018."},{"key":"926_CR7","first-page":"1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015: MMWR Recomm. Rep. 2015;64:1\u2013137.","journal-title":"Rep"},{"key":"926_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajog.2013.05.006","volume":"209","author":"C Kenyon","year":"2013","unstructured":"Kenyon C, Colebunders R, Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol. 2013;209:505\u201323.","journal-title":"Am J Obstet Gynecol"},{"key":"926_CR9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","volume":"22","author":"J Atashili","year":"2008","unstructured":"Atashili J, Poole C, Ndumbe PM, et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22:1493\u2013501.","journal-title":"AIDS."},{"key":"926_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.annepidem.2011.11.005","volume":"22","author":"MF Gallo","year":"2012","unstructured":"Gallo MF, Macaluso M, Warner L, et al. Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links. Ann Epidemiol. 2012;22:213\u201320.","journal-title":"Ann Epidemiol"},{"key":"926_CR11","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1086\/656739","volume":"51","author":"P Oakeshott","year":"2010","unstructured":"Oakeshott P, Aghaizu A, Hay P, et al. Is Mycoplasma genitalium in women the \u201cnew chlamydia?\u201d a community-based prospective cohort study. Clin Infect Dis. 2010;51:1160\u20136.","journal-title":"Clin Infect Dis"},{"key":"926_CR12","doi-asserted-by":"crossref","unstructured":"Lillis RA, Martin DH, Nsuami MJ. Mycoplasma genitalium infections in women attending a sexually transmitted disease clinic in New Orleans. Clin Infect Dis. 2019:459\u201365.","DOI":"10.1093\/cid\/ciy922"},{"key":"926_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/095646249100200407","volume":"2","author":"HM Palmer","year":"1991","unstructured":"Palmer HM, Gilroy CB, Claydon EJ, et al. Detection of Mycoplasma genitalium in the genitourinary tract of women by the polymerase chain reaction. Int J STD & AIDS. 1991;2:261\u20133.","journal-title":"Int J STD & AIDS"},{"key":"926_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1258\/0956462001916056","volume":"11","author":"EA Keane","year":"2000","unstructured":"Keane EA, Thomas J, Gilroy CB, et al. The association of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial vaginosis: observations on heterosexual women and their male partners. Int. J. STD & AIDS. 2000;11:356\u201360.","journal-title":"Int. J. STD & AIDS."},{"key":"926_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/cid\/ciy025","volume":"67","author":"AC Sena","year":"2018","unstructured":"Sena AC, Lee JY, Schwebke J, et al. A silent epidemic: the prevalence, incidence and persistence of Mycoplasma genitalium among young, asymptomatic high-risk women in the United States. Clin Infect Dis. 2018;67:73\u20139.","journal-title":"Clin Infect Dis"},{"key":"926_CR16","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1128\/JCM.02312-16","volume":"55","author":"SN Tabrizi","year":"2014","unstructured":"Tabrizi SN, Su J, Bradshaw CS, et al. Prospective evaluation of ResistancePlus MG, a new multiplex quantitative PCR assay for detection of Mycoplasma genitalium and macrolide resistance. J Clin Microbiol. 2014;55:1915\u20139.","journal-title":"J Clin Microbiol"},{"key":"926_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.diagmicrobio.2018.05.022","volume":"92","author":"CP Cartwright","year":"2018","unstructured":"Cartwright CP, Pherson AJ, Harris AB, et al. Multicenter study establishing the clinical validity of a nucleic-acid amplification-based assay for the diagnosis of bacterial vaginosis. Diagn Micro Infect Dis. 2018;92:173\u20138.","journal-title":"Diagn Micro Infect Dis"},{"key":"926_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","volume":"74","author":"R Amsel","year":"1983","unstructured":"Amsel R, Totten PA, Speigel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 1983;74:14\u201322.","journal-title":"Med"},{"key":"926_CR19","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1128\/JCM.00506-12","volume":"50","author":"CP Cartwright","year":"2012","unstructured":"Cartwright CP, Lembke BD, Ramachandran K, et al. Development and validation of a semiquantitative, multitarget PCR assay for the diagnosis of bacterial vaginosis. J Clin Microbiol. 2012;50:2321\u20139.","journal-title":"J Clin Microbiol"},{"key":"926_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297\u2013301.","journal-title":"J Clin Microbiol"},{"key":"926_CR21","doi-asserted-by":"crossref","unstructured":"Cartwright CP, Lembke BD, Ramachandran K, et al. Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women. J Clin Microbiol. 2013:3694\u20139.","DOI":"10.1128\/JCM.01537-13"},{"key":"926_CR22","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1128\/JCM.01053-16","volume":"54","author":"D Getman","year":"2016","unstructured":"Getman D, Jiang A, O\u2019Donnell M, Cohen S. Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J. Clin. Microbiol. 2016;54:2278\u201383.","journal-title":"J. Clin. Microbiol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-00926-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-020-00926-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-00926-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:07:10Z","timestamp":1616717230000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-020-00926-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,26]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1186\/s12905-020-00926-6","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,26]]},"assertion":[{"value":"6 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was conducted retrospectively using non-identifiable biospecimens. As such it was not necessary to obtain informed consent or IRB approval for the study under US Federal Law (45 CFR Part 46: Basic HHS Policy For Protection of Human Subjects).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Charles P. Cartwright is an employee of SpeeDx Pty. Ltd., the manufacturer of the ResistancePlus MG assay used in the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}